Toward an NGF-based therapy for Rett syndrome
Impact of extremely low frequency electromagnetic fields exposure on sleep quality and mental health in a Tunisian power plant: a cross-sectional study
Associations of psychological distress, gaming motives and internet gaming disorder in adolescents: a network analysis
Sex-specific impact of vitamin D and B9 concentrations on neuroticism: a polygenic score-based study
Mental health in the time of polycrisis: geopolitical determinants and modern psychiatry
Adult attachment and intimate relationship satisfaction among university students: the chain mediating roles of appreciation and sense of giving
The value of patient-focused drug development
Nature Medicine, Published online: 24 April 2026; doi:10.1038/s41591-026-04364-z
The value of patient-focused drug development
Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial
Nature Medicine, Published online: 24 April 2026; doi:10.1038/s41591-026-04354-1
In a biomarker-driven trial evaluating radiotherapy with erlotinib, everolimus or dasatinib in patients with newly diagnosed diffuse intrinsic pontine glioma, the primary endpoint of overall survival was not met, but features associated with long-term survival were defined, and everolimus emerged as a potential candidate for further testing.
Cross-reactive anti-prophage antibodies and bacterial heteroresistance implicated in phage therapeutic failure
Nature Medicine, Published online: 24 April 2026; doi:10.1038/s41591-026-04301-0
A 22-year-old patient with cystic fibrosis and chronic, drug-resistant Bordetella bronchialis infection received compassionate-use phage therapy. Serum samples revealed that pre-existing antiphage immunity existed before treatment, indicating that future studies must evaluate antiphage immunity across the entire treatment regimen.

